- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Tumor Inflammatory Microenvironment in Lung Cancer
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-17
DOI
10.3389/fphar.2021.688625
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of tumor microenvironment for pancreatic cancer therapy
- (2021) Xu Huang et al. BIOMATERIALS
- Immunogenic cell death-inducing chemotherapeutic nanoformulations potentiate combination chemoimmunotherapy
- (2021) Jianhua Liu et al. MATERIALS & DESIGN
- Ultrasound-Augmented Mitochondrial Calcium Ion Overload by Calcium Nanomodulator to Induce Immunogenic Cell Death
- (2021) Pan Zheng et al. NANO LETTERS
- Schiff-Linked PEGylated Doxorubicin Prodrug Forming pH-Responsive Nanoparticles With High Drug Loading and Effective Anticancer Therapy
- (2021) Jian Song et al. Frontiers in Oncology
- Berberine induces dose-dependent quiescence and apoptosis in A549 cancer cells by modulating cell cyclins and inflammation independent of mTOR pathway
- (2020) Ravi Kumar et al. LIFE SCIENCES
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences
- (2019) Florian R. Greten et al. IMMUNITY
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis
- (2019) Bridie S. Mulholland et al. Current Osteoporosis Reports
- Ellagitannins from Punica granatum leaves suppress microsomal prostaglandin E synthase-1 expression and induce lung cancer cells to undergo apoptosis
- (2019) Keisuke Toda et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Targeted pH-responsive polyion complex micelle for controlled intracellular drug delivery
- (2019) Pan Zheng et al. CHINESE CHEMICAL LETTERS
- Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
- (2019) Rei Mizuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy
- (2019) Jeffrey C. Thompson et al. LUNG CANCER
- The regulation and importance of monocyte chemoattractant protein-1
- (2018) Vanessa Bianconi et al. CURRENT OPINION IN HEMATOLOGY
- Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
- (2018) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- Prospective Analyses of Cytokine Mediation of Sleep and Survival in the Context of Advanced Cancer
- (2018) Jennifer L. Steel et al. PSYCHOSOMATIC MEDICINE
- TGF-β Signaling in Lung Health and Disease
- (2018) Akira Saito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interleukin-1 Beta—A Friend or Foe in Malignancies?
- (2018) Rebekka Bent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-1β Induces Fascin Expression and Increases Cancer Invasion
- (2018) MIN KYEONG LEE et al. ANTICANCER RESEARCH
- IL-1 and IL-1 regulatory pathways in cancer progression and therapy
- (2017) Alberto Mantovani et al. IMMUNOLOGICAL REVIEWS
- S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
- (2017) Benjamin Weichand et al. JOURNAL OF EXPERIMENTAL MEDICINE
- EMT and inflammation: inseparable actors of cancer progression
- (2017) Meggy Suarez-Carmona et al. Molecular Oncology
- Cell plasticity in epithelial homeostasis and tumorigenesis
- (2017) Julia Varga et al. NATURE CELL BIOLOGY
- IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model
- (2017) Kailing Wang et al. Oncotarget
- Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway
- (2017) Limin Wang et al. Oncotarget
- Macrophages, Inflammation, and Lung Cancer
- (2016) Emma M. Conway et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Fabrication of pH-Responsive Nanoparticles with an AIE Feature for Imaging Intracellular Drug Delivery
- (2016) Xing Wang et al. BIOMACROMOLECULES
- IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer
- (2016) M. S. Caetano et al. CANCER RESEARCH
- Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
- (2016) Ulrike Billmeier et al. WORLD JOURNAL OF GASTROENTEROLOGY
- IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
- (2016) Romaine I. Fernando et al. Oncotarget
- Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
- (2015) Xin Ye et al. NATURE
- Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
- (2015) Selma Rivas-Fuentes et al. Journal of Cancer
- The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
- (2015) Antonino Bruno et al. NEOPLASIA
- Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
- (2014) Kodappully Sivaraman Siveen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature
- (2014) F. M. Millimouno et al. Cancer Prevention Research
- Molecular Pathways: Linking Tumor Microenvironment to Epithelial-Mesenchymal Transition in Metastasis
- (2014) H.-Y. Jung et al. CLINICAL CANCER RESEARCH
- Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer
- (2014) Ji-Won Kim et al. Cancer Research and Treatment
- Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
- (2013) S. You et al. MOLECULAR CANCER THERAPEUTICS
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Pulmonary Oxidative Stress, Inflammation and Cancer: Respirable Particulate Matter, Fibrous Dusts and Ozone as Major Causes of Lung Carcinogenesis through Reactive Oxygen Species Mechanisms
- (2013) Athanasios Valavanidis et al. International Journal of Environmental Research and Public Health
- Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium
- (2012) D. R. Brenner et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
- (2012) Ramaswamy Govindan et al. CELL
- Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
- (2012) Theodore S. Johnson et al. IMMUNOLOGICAL INVESTIGATIONS
- An NF-κB pathway–mediated positive feedback loop amplifies Ras activity to pathological levels in mice
- (2012) Jaroslaw Daniluk et al. JOURNAL OF CLINICAL INVESTIGATION
- Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ
- (2012) S Jin et al. ONCOGENE
- STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma
- (2012) Brendan D. Looyenga et al. PLoS One
- GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression
- (2012) Claudia M. Gutschalk et al. Cancer Medicine
- VAP-1–Mediated M2 Macrophage Infiltration Underlies IL-1β– but Not VEGF-A–Induced Lymph- and Angiogenesis
- (2011) Shintaro Nakao et al. AMERICAN JOURNAL OF PATHOLOGY
- HIF-1α Confers Aggressive Malignant Traits on Human Tumor Cells Independent of Its Canonical Transcriptional Function
- (2011) Young-Gun Yoo et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- High transforming growth factor β expression represents an important prognostic parameter for surgically resected non–small cell lung cancer
- (2011) William Sterlacci et al. HUMAN PATHOLOGY
- Developmental antiangiogenic agents for the treatment of Non-Small Cell Lung Cancer (NSCLC)
- (2011) George R. Blumenschein INVESTIGATIONAL NEW DRUGS
- Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer
- (2011) Rui Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- JAK1 Activates STAT3 Activity in Non-Small-Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 Signaling
- (2011) L. Song et al. MOLECULAR CANCER THERAPEUTICS
- NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target
- (2010) Wenshu Chen Frontiers in Bioscience-Landmark
- Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk
- (2010) Ana L. Teixeira et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer
- (2010) Roy M. Bremnes et al. Journal of Thoracic Oncology
- Construction of NF-κB-targeting RNAi adenovirus vector and the effect of NF-κB pathway on proliferation and apoptosis of vascular endothelial cells
- (2010) Gang Chen et al. MOLECULAR BIOLOGY REPORTS
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
- (2010) Young Lim Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy
- (2009) Yong Lin et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer
- (2008) E. R. Brown et al. ANNALS OF ONCOLOGY
- Inflammation in lung carcinogenesis: New targets for lung cancer chemoprevention and treatment
- (2008) Jay M. Lee et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?
- (2008) D. Daniel et al. CURRENT CANCER DRUG TARGETS
- “Re-educating” tumor-associated macrophages by targeting NF-κB
- (2008) Thorsten Hagemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inflammation and Lung Cancer: Roles of Reactive Oxygen/Nitrogen Species
- (2008) Neelam Azad et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
- Inflammation: Gearing the journey to cancer
- (2008) J KUNDU et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
- (2008) Sandra Rebouissou et al. NATURE
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
- (2008) Jordi Rius et al. NATURE
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started